However, a recent study showed that PTPN3 inhibits lung cancer cell proliferation and migration by promoting the endocytic degradation of EGFR, indicating that PTPN3 may act as a tumour suppressor in lung cancer through its modulation of EGFR signalling19. This evidence concerns the gene EGFR and neoplasm.